Seban RD, Champion L, Bellesoeur A, Vincent-Salomon A, et al. Clinical Potential of HER2 PET as a Predictive Biomarker to Guide the Use of Trastuzumab Deruxtecan in Breast Cancer Patients. J Nucl Med 2023 May 25:265434. doi: 10.2967/jnumed.123.265434.
PMID: 37230529